-+ 0.00%
-+ 0.00%
-+ 0.00%

Senzime Wins Regulatory Nod to Begin TetraGraph System Sales in Japan

MT Newswires·12/17/2025 08:48:23
Listen to the news
08:48 AM EST, 12/17/2025 (MT Newswires) -- Senzime (SEZI.ST) secured approval from Japan's Pharmaceuticals and Medical Devices Agency to sell the neuromuscular function TetraGraph system in the country. Subsequently, the Swedish medical device company secured an order for 80 of its TetraGraph monitors to be delivered to Japan in the fourth quarter of 2025, according to a Wednesday release. Senzime has a long-standing agreement with Fukuda Denshi to commercialize the TetraGraph portfolio in Japan.